Ocugen (OCGN) EBIAT (2016 - 2025)
Ocugen's EBIAT history spans 12 years, with the latest figure at -$17.7 million for Q4 2025.
- For Q4 2025, EBIAT fell 27.1% year-over-year to -$17.7 million; the TTM value through Dec 2025 reached -$67.8 million, down 25.4%, while the annual FY2025 figure was -$67.8 million, 25.32% down from the prior year.
- EBIAT reached -$17.7 million in Q4 2025 per OCGN's latest filing, up from -$20.1 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$7.1 million in Q1 2021 to a low of -$26.0 million in Q2 2021.
- Average EBIAT over 5 years is -$16.5 million, with a median of -$15.3 million recorded in 2024.
- Peak YoY movement for EBIAT: tumbled 618.1% in 2021, then surged 51.0% in 2023.
- A 5-year view of EBIAT shows it stood at -$14.6 million in 2021, then plummeted by 53.56% to -$22.4 million in 2022, then surged by 50.97% to -$11.0 million in 2023, then decreased by 26.85% to -$13.9 million in 2024, then dropped by 27.1% to -$17.7 million in 2025.
- Per Business Quant, the three most recent readings for OCGN's EBIAT are -$17.7 million (Q4 2025), -$20.1 million (Q3 2025), and -$14.7 million (Q2 2025).